AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

El.En.

Interim / Quarterly Report Sep 12, 2024

4393_cp_2024-09-12_5f8e15be-2675-4deb-a954-dfd882b34853.pdf

Interim / Quarterly Report

Open in Viewer

Opens in native device viewer

COMPANY PRESENTATION

Conference Call H1 2024 Financial results

Sept. 12th , 2024

DISCLAIMER

2

Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-looking statements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.

HIGHLIGHTS – H1 2024

3

&
P
L
/
/
3
0
0
6
2
3
% /
/
3
0
0
6
2
4
% %
V
a
r.
R
e
v
e
n
u
e
s
3
4
5
6
2
5
3
1
2
9
6
2
%
9
5
-
,
E
B
I
T
3
8
8
7
4
2
%
1
1
,
3
8
0
4
1
0
9
%
1
,
2
%
1
1
-
,
R
e
v
e
n
u
e
s
/
/
3
0
0
6
2
3
% /
/
3
0
0
6
2
4
% %
V
a
r.
d
l
i
M
e
c
a
1
9
8
5
0
5
%
5
7
4
,
1
9
5
0
6
9
%
6
2
3
,
%
1
7
-
,
l
d
I
i
t
n
s
r
a
u
1
4
1
2
0
7
4
2
6
%
,
1
1
8
9
3
7
3
%
7
7
,
1
9
9
%
-
,

INCOME STATEMENT – H1 2024

SDIR
CERTIFIED

4

'0
E
0
0
u
r
o
/
/
3
0
0
6
2
3
% /
/
3
0
0
6
2
4
% %
V
a
r.
l
d
M
i
e
c
a
1
9
8
5
0
5
%
5
7,
4
1
9
5
0
6
9
%
6
2,
3
%
1,
7
-
d
l
I
i
t
n
u
s
r
a
1
4
7
1
2
0
4
2,
6
%
1
1
7
8
9
3
3
7,
7
%
1
9,
9
%
-
R
e
v
e
n
u
e
s
3
4
6
2
5
5
1
0
0
0
%
,
3
1
2
9
6
2
1
0
0
0
%
,
9
%
5
-
,
i
G
r
o
s
s
m
a
r
g
n
1
3
1
4
7
3
%
3
8
0
,
1
2
8
8
0
6
%
4
1
2
,
%
2
0
-
,
O
i
E
t
p
e
r
a
n
g
p
e
n
s
e
s
x
3
0
6
2
2
8
9
%
,
3
3
9
1
4
0
0
%
1
,
2
%
5
,
f
f
S
t
a
e
s
p
e
n
s
e
s
1
9
5
5
7
1
6
0
%
,
6
0
2
0
5
1
9
%
7
,
1
%
5
,
E
B
I
T
D
A
4
5
6
5
4
1
3
2
%
,
4
1
3
9
1
1
3
2
%
,
9
3
%
-
,
l
D
t.
e
p
r.
a
m
o
r
a
c
c
r
u
a
s
,
,
6
7
8
0
%
2
0
,
7
2
1
1
%
2
3
,
%
6
4
,
E
B
I
T
3
8
8
7
4
2
%
1
1
,
3
8
0
4
1
0
9
%
1
,
2
%
1
1
-
,
f
(
)
h
i
i
N
t
e
n
a
n
c
n
c
o
m
e
c
a
r
g
e
s
(
)
1
0
2
8
0
3
%
-
,
(
)
6
8
4
0
1
%
-
,
%
5
4
5
-
,
h
(
)
O
i
t
t
e
r
n
c
o
m
e
e
x
p
e
n
s
e
n
e
(
)
5
%
0
0
,
4
7
8
4
%
1
5
,
E
B
T
3
8
2
7
4
0
9
%
1
,
3
8
9
4
7
2
3
%
1
,
%
1
7
,
I
t
n
c
o
m
e
a
e
s
x
0
9
9
1
1
3
2
%
,
0
8
1
1
4
3
%
5
,
0
%
5
,
M
i
i
i
t
n
o
r
e
s
1
0
7
5
0
3
%
,
1
5
1
0
0
%
,
8
6
0
%
-
,
N
E
T
I
N
C
O
M
E
2
5
7
7
6
7
5
%
,
2
7
2
9
7
8
7
%
,
5
9
%
,

BALANCE SHEET – H1 2024

'0
E
0
0
r
o
u
/
/
3
1
1
2
2
3
/
/
3
0
0
6
2
4
%
V
a
r.
l
T
t
t
t
o
a
n
o
n
c
r
r
e
n
a
s
s
e
s
u
1
6
6
2
0
0
1
5
2
9
1
4
%
8
0
-
,
k
l
i
C
i
N
W
t
t
e
o
r
n
g
a
p
a
2
3
0
9
4
4
2
3
9
4
7
1
9
%
1
,
/
h
b
l
b
l
O
i
S
T
t
e
r
r
e
c
e
v
a
e
s
p
a
y
a
e
s
(
)
2
5
4
4
4
(
)
9
9
1
2
4
8
0
%
-
,
f
l
N
i
i
i
i
t
t
e
n
a
n
a
p
o
s
o
n
c
5
4
5
8
6
6
8
6
4
5
%
2
5
8
,
l
b
l
i
i
i
i
L
t
t
o
n
g
e
r
m
a
e
s
2
1
5
3
3
1
8
8
8
4
%
1
2
3
-
,
i
N
E
t
t
e
q
u
y
3
4
8
7
5
5
3
8
7
5
5
5
3
2
%
,
l
l
d
i
N
t
t
e
c
a
p
a
e
m
p
o
e
y
3
2
0
8
7
2
3
1
8
9
1
0
%
0
6
-
,
k
l
l
i
i
N
W
C
t
t
e
o
r
n
g
a
p
a
o
n
s
a
e
s
%
3
3
3
,
%
3
7
5
,
O
C
R
E
2
2
%
7
,
2
1
%
4
,
/
(
l
l
d
)
E
B
I
T
N
i
t
t
e
a
p
a
e
m
p
o
e
c
y
i
O
C
t
p
e
r
a
n
g
a
p
e
x
1
3
5
4
6
8
2
0
5

Cash Flow – H1 2024

7

Revenue Breakdown by Business

Medical: -2%

Revenue Breakdown by Area

9

2024 Guidance

EBIT 2024 > EBIT 2023

CONTACTS

El.En. S.P.A. Enrico Romagnoli Investor Relations Manager tel. +39 055-8826807 E-mail: [email protected]

POLYTEMS HIR

Financial Communication, IR and Press Office Bianca Fersini Mastelloni - [email protected] Silvia Marongiu - [email protected] Tel. +39 06-69923324

Talk to a Data Expert

Have a question? We'll get back to you promptly.